Nitric oxide biology and the liver: Report of an AASLD research workshop

January 1, 2004HepatologyOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

Synthesize scientific findings from the AASLD research workshop detailing nitric oxide enzymology, signaling pathways, and its regulatory roles in liver health and disease.
Reviewed biochemical characterizations of nitric oxide synthase isoforms (eNOS, iNOS, nNOS) and kinetic simulation models of enzyme catalysis.
Evaluated preclinical cell culture and rodent knockout models examining downstream NO signaling targets, including guanylate cyclase, S-nitrosylation, and oxidant interactions.
NO mediates hepatic vascular resistance primarily via the soluble guanylate cyclase and cGMP pathway, where eNOS downregulation directly contributes to sinusoidal endothelial dysfunction and portal hypertension.
Inducible NOS exerts dual physiological actions, providing hepatoprotection against apoptosis via caspase S-nitrosylation while also contributing to oxidative cell damage through peroxynitrite formation during inflammation.
Preclinical interventions utilizing statin-induced eNOS activation or liver-selective NO-donating compounds effectively attenuate hepatic vascular resistance and prevent sinusoidal obstruction.

Design

Review

Nitric oxide pathways in liver disease remain exploratory; this synthesis leaves open therapeutic translation pending targeted trials.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Rockey et al. (2004) studied this question.

View Full Paper

Ask AI

Bookmark

Share